The Experts below are selected from a list of 7059 Experts worldwide ranked by ideXlab platform
Peng-hui Wang - One of the best experts on this subject based on the ideXlab platform.
-
the short term outcome of laser in the management of female pelvic floor disorders focus on stress Urine Incontinence and sexual dysfunction
Taiwanese Journal of Obstetrics & Gynecology, 2018Co-Authors: Hsin-yin Lin, Hsiao-wen Tsai, Kuan-hao Tsui, Zi-han Lin, Wen-shiung Liou, Peng-hui WangAbstract:Abstract Objective Female pelvic floor disorders, including female stress urinary Incontinence (SUI) or sexual dysfunction are notorious for affecting the quality of women's life. It is reported that laser therapy might result in collagen remodeling and improvement in tissue firmness. The study was conducted to evaluate the short-term outcome of female pelvic floor disorders treated by laser therapy. Materials and methods Women with self-reported symptoms of female pelvic floor disorders (limited to SUI and sexual dysfunction) were included in the study. The participants were treated with the Er:YAG laser or the fractional microablative carbon dioxide (CO2) laser system. The therapeutic effect was focused on SUI symptoms and sexual dysfunction. Results There were 31 women underwent laser treatment, including 21 patients treated with Erbium:YAG laser and 10 treated with CO2 laser. In the Erbium:YAG laser group, International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ- SF) scores were dropped from 8.25 ± 5.66 to 5.00 ± 3.99 (P = 0.007); and in the CO2 laser group, scores were dropped from 11.11 ± 6.85 to 6.44 ± 4.25 (P = 0.035), contributing to the drop of ICI-Q-SF scores from 9.14 ± 6.08 to 5.45 ± 4.05 for all enrolled patients (P = 0.001). However, objective measure using pad test did not show a statistically significant difference between before and after treatment (from 3.20 ± 5.84 g to 1.54 ± 3.18 g, P = 0.224). Sexual dysfunction was improved in 13 patients (44.83%), but Female Sexual Function Index (FSFI) scores were not different before and after laser treatment (44.22 ± 23.36 vs. 44.09 ± 24.51, P = 0.389). Conclusion Laser therapy either by Erbium:YAG laser or CO2 laser seemed to be useful for female pelvic floor disorders, especially on improvement of SUI symptoms; however, the effectiveness needs further confirmation.
-
The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress Urine Incontinence and sexual dysfunction
Elsevier, 2018Co-Authors: Hsin-yin Lin, Hsiao-wen Tsai, Kuan-hao Tsui, Zi-han Lin, Wen-shiung Liou, Peng-hui WangAbstract:Objective: Female pelvic floor disorders, including female stress urinary Incontinence (SUI) or sexual dysfunction are notorious for affecting the quality of women's life. It is reported that laser therapy might result in collagen remodeling and improvement in tissue firmness. The study was conducted to evaluate the short-term outcome of female pelvic floor disorders treated by laser therapy. Materials and methods: Women with self-reported symptoms of female pelvic floor disorders (limited to SUI and sexual dysfunction) were included in the study. The participants were treated with the Er:YAG laser or the fractional microablative carbon dioxide (CO2) laser system. The therapeutic effect was focused on SUI symptoms and sexual dysfunction. Results: There were 31 women underwent laser treatment, including 21 patients treated with Erbium:YAG laser and 10 treated with CO2 laser. In the Erbium:YAG laser group, International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ- SF) scores were dropped from 8.25 ± 5.66 to 5.00 ± 3.99 (P = 0.007); and in the CO2 laser group, scores were dropped from 11.11 ± 6.85 to 6.44 ± 4.25 (P = 0.035), contributing to the drop of ICI-Q-SF scores from 9.14 ± 6.08 to 5.45 ± 4.05 for all enrolled patients (P = 0.001). However, objective measure using pad test did not show a statistically significant difference between before and after treatment (from 3.20 ± 5.84 g to 1.54 ± 3.18 g, P = 0.224). Sexual dysfunction was improved in 13 patients (44.83%), but Female Sexual Function Index (FSFI) scores were not different before and after laser treatment (44.22 ± 23.36 vs. 44.09 ± 24.51, P = 0.389). Conclusion: Laser therapy either by Erbium:YAG laser or CO2 laser seemed to be useful for female pelvic floor disorders, especially on improvement of SUI symptoms; however, the effectiveness needs further confirmation. Keywords: CO2 laser, Erbium:YAG laser, Female pelvic floor disorders, Sexual dysfunction, Stress urinary incontinenc
Hsin-yin Lin - One of the best experts on this subject based on the ideXlab platform.
-
the short term outcome of laser in the management of female pelvic floor disorders focus on stress Urine Incontinence and sexual dysfunction
Taiwanese Journal of Obstetrics & Gynecology, 2018Co-Authors: Hsin-yin Lin, Hsiao-wen Tsai, Kuan-hao Tsui, Zi-han Lin, Wen-shiung Liou, Peng-hui WangAbstract:Abstract Objective Female pelvic floor disorders, including female stress urinary Incontinence (SUI) or sexual dysfunction are notorious for affecting the quality of women's life. It is reported that laser therapy might result in collagen remodeling and improvement in tissue firmness. The study was conducted to evaluate the short-term outcome of female pelvic floor disorders treated by laser therapy. Materials and methods Women with self-reported symptoms of female pelvic floor disorders (limited to SUI and sexual dysfunction) were included in the study. The participants were treated with the Er:YAG laser or the fractional microablative carbon dioxide (CO2) laser system. The therapeutic effect was focused on SUI symptoms and sexual dysfunction. Results There were 31 women underwent laser treatment, including 21 patients treated with Erbium:YAG laser and 10 treated with CO2 laser. In the Erbium:YAG laser group, International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ- SF) scores were dropped from 8.25 ± 5.66 to 5.00 ± 3.99 (P = 0.007); and in the CO2 laser group, scores were dropped from 11.11 ± 6.85 to 6.44 ± 4.25 (P = 0.035), contributing to the drop of ICI-Q-SF scores from 9.14 ± 6.08 to 5.45 ± 4.05 for all enrolled patients (P = 0.001). However, objective measure using pad test did not show a statistically significant difference between before and after treatment (from 3.20 ± 5.84 g to 1.54 ± 3.18 g, P = 0.224). Sexual dysfunction was improved in 13 patients (44.83%), but Female Sexual Function Index (FSFI) scores were not different before and after laser treatment (44.22 ± 23.36 vs. 44.09 ± 24.51, P = 0.389). Conclusion Laser therapy either by Erbium:YAG laser or CO2 laser seemed to be useful for female pelvic floor disorders, especially on improvement of SUI symptoms; however, the effectiveness needs further confirmation.
-
The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress Urine Incontinence and sexual dysfunction
Elsevier, 2018Co-Authors: Hsin-yin Lin, Hsiao-wen Tsai, Kuan-hao Tsui, Zi-han Lin, Wen-shiung Liou, Peng-hui WangAbstract:Objective: Female pelvic floor disorders, including female stress urinary Incontinence (SUI) or sexual dysfunction are notorious for affecting the quality of women's life. It is reported that laser therapy might result in collagen remodeling and improvement in tissue firmness. The study was conducted to evaluate the short-term outcome of female pelvic floor disorders treated by laser therapy. Materials and methods: Women with self-reported symptoms of female pelvic floor disorders (limited to SUI and sexual dysfunction) were included in the study. The participants were treated with the Er:YAG laser or the fractional microablative carbon dioxide (CO2) laser system. The therapeutic effect was focused on SUI symptoms and sexual dysfunction. Results: There were 31 women underwent laser treatment, including 21 patients treated with Erbium:YAG laser and 10 treated with CO2 laser. In the Erbium:YAG laser group, International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ- SF) scores were dropped from 8.25 ± 5.66 to 5.00 ± 3.99 (P = 0.007); and in the CO2 laser group, scores were dropped from 11.11 ± 6.85 to 6.44 ± 4.25 (P = 0.035), contributing to the drop of ICI-Q-SF scores from 9.14 ± 6.08 to 5.45 ± 4.05 for all enrolled patients (P = 0.001). However, objective measure using pad test did not show a statistically significant difference between before and after treatment (from 3.20 ± 5.84 g to 1.54 ± 3.18 g, P = 0.224). Sexual dysfunction was improved in 13 patients (44.83%), but Female Sexual Function Index (FSFI) scores were not different before and after laser treatment (44.22 ± 23.36 vs. 44.09 ± 24.51, P = 0.389). Conclusion: Laser therapy either by Erbium:YAG laser or CO2 laser seemed to be useful for female pelvic floor disorders, especially on improvement of SUI symptoms; however, the effectiveness needs further confirmation. Keywords: CO2 laser, Erbium:YAG laser, Female pelvic floor disorders, Sexual dysfunction, Stress urinary incontinenc
Inderbir S Gill - One of the best experts on this subject based on the ideXlab platform.
-
ejaculatory Urine Incontinence after radical prostatectomy
Urology, 2006Co-Authors: Robert Abouassaly, Brian R Lane, Milton M Lakin, Eric A Klein, Inderbir S GillAbstract:Abstract Objectives Urinary Incontinence and erectile dysfunction remain the long-term complications that affect most patients’ lives after radical prostatectomy. Previous reports evaluating Incontinence have focused on volumes of Urine loss and daily pad use to assess these issues. We have observed that small volumes of urinary Incontinence during sexual activity can be just as disconcerting to patients. We attempt to further describe and assess the phenomenon of urinary Incontinence with ejaculation in a series of patients. Methods We reviewed the experience of one physician who received referrals for the treatment of erectile dysfunction after radical prostatectomy from July 2002 to March 2005 and identified 26 men experiencing Urine leak predominantly during ejaculation. Questionnaires assessing urinary Incontinence were sent to all these patients. Results The mean age was 62 years (range 54 to 73). Sixteen patients underwent bilateral nerve-sparing, five unilateral nerve-sparing, and five nonnerve-sparing radical retropubic prostatectomy. At a median follow-up of 42 months (range 15 to 118), all patients had experienced Urine leakage (volume 0.5 teaspoon to 1 cup) during ejaculation. The Incontinence questionnaire revealed that most patients had mild Incontinence; however, they experienced ejaculatory Urine Incontinence “most, or all of the time” and considered it a “big problem.” Conclusions Although the prevalence of ejaculatory Urine Incontinence is unclear, in our experience it occurs often enough to be considered a part of the routine postprostatectomy evaluation. A better understanding of the pathophysiology of postprostatectomy Incontinence will lead to targeted therapy and an improved quality of life for the patient.
Niko Heiss - One of the best experts on this subject based on the ideXlab platform.
-
female Urine Incontinence vaginal erbium laser vel effectiveness and safety
Hormone Molecular Biology and Clinical Investigation, 2020Co-Authors: David Elia, Marco Gambiacciani, Jean Marc Ayoubi, Nicolas Berreni, Jean Marc Bohbot, Philippe Descamps, Rene Druckmann, Hugues Geoffrion, Francois Haab, Niko HeissAbstract:Urinary Incontinence is a common health problem that impacts the quality of life of women at different ages. Its physiopathology is not unequivocal, and it is necessary to consider the stress urinary Incontinence (SUI), the overactive bladder syndrome and the mixed Incontinence (MUI). According to the type of Incontinence, its impact on the quality of life and age of the patients, therapeutic strategies are currently summarized in physiotherapy, surgery and drug treatments. We already know the benefit/risk ratio of each of these strategies. Our objective is to evaluate the potential effectiveness and safety of the VEL, an innovative vaginal laser technique (VEL - Vaginal Erbium Laser, erbium yttrium-aluminum-garnet -Er: YAG) a non-invasive laser proposed as a treatment for SUI, overactive bladder syndrome and MUI. The mechanisms of action of lasers are discussed in general and those of VEL in particular with the description of the Smooth® mode. To do this, we have collected the 21 published studies including the first randomized vs. placebo and two pilot studies of intra-urethral VEL. In conclusion: VEL procedures already have their place between the rehabilitation of the perineal floor and surgery. Further properly sized, randomized studies are needed to evaluate the laser treatments in comparison with other therapies, as well as to assess the duration of the therapeutic effects and the safety of repeated applications.
Zi-han Lin - One of the best experts on this subject based on the ideXlab platform.
-
the short term outcome of laser in the management of female pelvic floor disorders focus on stress Urine Incontinence and sexual dysfunction
Taiwanese Journal of Obstetrics & Gynecology, 2018Co-Authors: Hsin-yin Lin, Hsiao-wen Tsai, Kuan-hao Tsui, Zi-han Lin, Wen-shiung Liou, Peng-hui WangAbstract:Abstract Objective Female pelvic floor disorders, including female stress urinary Incontinence (SUI) or sexual dysfunction are notorious for affecting the quality of women's life. It is reported that laser therapy might result in collagen remodeling and improvement in tissue firmness. The study was conducted to evaluate the short-term outcome of female pelvic floor disorders treated by laser therapy. Materials and methods Women with self-reported symptoms of female pelvic floor disorders (limited to SUI and sexual dysfunction) were included in the study. The participants were treated with the Er:YAG laser or the fractional microablative carbon dioxide (CO2) laser system. The therapeutic effect was focused on SUI symptoms and sexual dysfunction. Results There were 31 women underwent laser treatment, including 21 patients treated with Erbium:YAG laser and 10 treated with CO2 laser. In the Erbium:YAG laser group, International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ- SF) scores were dropped from 8.25 ± 5.66 to 5.00 ± 3.99 (P = 0.007); and in the CO2 laser group, scores were dropped from 11.11 ± 6.85 to 6.44 ± 4.25 (P = 0.035), contributing to the drop of ICI-Q-SF scores from 9.14 ± 6.08 to 5.45 ± 4.05 for all enrolled patients (P = 0.001). However, objective measure using pad test did not show a statistically significant difference between before and after treatment (from 3.20 ± 5.84 g to 1.54 ± 3.18 g, P = 0.224). Sexual dysfunction was improved in 13 patients (44.83%), but Female Sexual Function Index (FSFI) scores were not different before and after laser treatment (44.22 ± 23.36 vs. 44.09 ± 24.51, P = 0.389). Conclusion Laser therapy either by Erbium:YAG laser or CO2 laser seemed to be useful for female pelvic floor disorders, especially on improvement of SUI symptoms; however, the effectiveness needs further confirmation.
-
The short-term outcome of laser in the management of female pelvic floor disorders: Focus on stress Urine Incontinence and sexual dysfunction
Elsevier, 2018Co-Authors: Hsin-yin Lin, Hsiao-wen Tsai, Kuan-hao Tsui, Zi-han Lin, Wen-shiung Liou, Peng-hui WangAbstract:Objective: Female pelvic floor disorders, including female stress urinary Incontinence (SUI) or sexual dysfunction are notorious for affecting the quality of women's life. It is reported that laser therapy might result in collagen remodeling and improvement in tissue firmness. The study was conducted to evaluate the short-term outcome of female pelvic floor disorders treated by laser therapy. Materials and methods: Women with self-reported symptoms of female pelvic floor disorders (limited to SUI and sexual dysfunction) were included in the study. The participants were treated with the Er:YAG laser or the fractional microablative carbon dioxide (CO2) laser system. The therapeutic effect was focused on SUI symptoms and sexual dysfunction. Results: There were 31 women underwent laser treatment, including 21 patients treated with Erbium:YAG laser and 10 treated with CO2 laser. In the Erbium:YAG laser group, International Consultation on Incontinence Questionnaire – Urinary Incontinence Short Form (ICIQ- SF) scores were dropped from 8.25 ± 5.66 to 5.00 ± 3.99 (P = 0.007); and in the CO2 laser group, scores were dropped from 11.11 ± 6.85 to 6.44 ± 4.25 (P = 0.035), contributing to the drop of ICI-Q-SF scores from 9.14 ± 6.08 to 5.45 ± 4.05 for all enrolled patients (P = 0.001). However, objective measure using pad test did not show a statistically significant difference between before and after treatment (from 3.20 ± 5.84 g to 1.54 ± 3.18 g, P = 0.224). Sexual dysfunction was improved in 13 patients (44.83%), but Female Sexual Function Index (FSFI) scores were not different before and after laser treatment (44.22 ± 23.36 vs. 44.09 ± 24.51, P = 0.389). Conclusion: Laser therapy either by Erbium:YAG laser or CO2 laser seemed to be useful for female pelvic floor disorders, especially on improvement of SUI symptoms; however, the effectiveness needs further confirmation. Keywords: CO2 laser, Erbium:YAG laser, Female pelvic floor disorders, Sexual dysfunction, Stress urinary incontinenc
